iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation

NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced members of its management team will participate in the following investor conferences this winter, which will include hosting meetings around the annual J.P. Morgan Healthcare Conference.

LifeSci Advisors 15^th Annual Corporate Access Event
Date: Monday, January 12^th
Location: The Beacon Grand, San Francisco, Calif.
Format: One-on-one meetings with management

Additional “JPM Week” Investor Meetings
Date: Monday, January 12^th through Wednesday, January 14^th
Location: San Francisco, Calif.
Format: One-on-one meetings with management

BTIG 13th Annual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Date: February 9^{th –} 11^th
Location: Cliff Lodge, Snowbird, Utah
Format: One-on-one meetings and skiing with management

To request an in-person meeting with management on Monday, January 12^th, during the week of the 44^th Annual J.P. Morgan Healthcare Conference, either register at LifeSci Partners Corporate Access Event 2026 or contact our LifeSci Partners representatives Alexandra Grossman (alex@lifesciadvisors.com). For meetings at the BTIG conference, please contact your sales representative at BTIG.

About Insight Molecular Diagnostics, Inc.

Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.Insight Molecular Diagnostics.com/ for more information.

Investor Contact:
Doug Farrell
LifeSci Advisors LLC
dfarrell@lifesciadvisors.com